1
|
Inanaga M, Yoneji W, Ozaki K. Localized pleural mesothelioma in a dog. J Comp Pathol 2023; 207:25-29. [PMID: 37922825 DOI: 10.1016/j.jcpa.2023.09.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2023] [Revised: 08/18/2023] [Accepted: 09/29/2023] [Indexed: 11/07/2023]
Abstract
Malignant mesotheliomas with localized growth are extremely rare in dogs. A 9-year-old male dog presented with a localized tumour that originated from the parietal pleura and had polypoid growth in the thoracic cavity. Histological examination revealed that the tumour consisted of tubular formations with scattered cysts and minimal papillary growth pattern. Neoplastic cells were immunopositive for mesothelial markers (calretinin and Wilms' tumour gene 1) and negative for carcinoma markers (thyroid transcription factor 1 and tumour protein 63). The animal was alive with no recurrence or metastasis/dissemination 11 months after surgery. To the best of our knowledge, this is the first report of a localized mesothelioma in a dog without metastasis/dissemination and highlights the value of mesothelial markers for an accurate diagnosis.
Collapse
Affiliation(s)
- Minori Inanaga
- Laboratory of Pathology, Faculty of Pharmaceutical Science, Setsunan University, 45-1 Nagaotohgecho, Hirakata, Osaka 573-0101, Japan
| | - Wakana Yoneji
- Nara Animal Referral Clinic, 5-20-7 Mitsugarasu, Nara 631-0061, Japan
| | - Kiyokazu Ozaki
- Laboratory of Pathology, Faculty of Pharmaceutical Science, Setsunan University, 45-1 Nagaotohgecho, Hirakata, Osaka 573-0101, Japan.
| |
Collapse
|
2
|
Kuboyama Y, Yamada Y, Kohashi K, Toda Y, Kawakami K, Kitahara D, Nishiyama K, Hiraki Y, Oya M, Oda Y. Three cases of synovial sarcoma of gastric wall: A case report and review of the literature. Pathol Res Pract 2021; 219:153352. [PMID: 33582394 DOI: 10.1016/j.prp.2021.153352] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/29/2020] [Revised: 01/22/2021] [Accepted: 01/25/2021] [Indexed: 12/16/2022]
Abstract
Synovial sarcoma (SS) is a malignant soft tissue neoplasm that occurs in various parts of the human body, but most commonly affects the extremities. Its diagnosis of synovial sarcoma often requires adjunctive techniques such as immunohistochemical staining and molecular studies, especially for synovial sarcoma at unusual locations. SS at a gastrointestinal location is exceedingly rare. We report here three cases of primary gastric synovial sarcoma. Malignant gastric mesenchymal tumor has many differential diagnoses other than synovial sarcoma, such as gastrointestinal stromal tumor (GIST), leiomyosarcoma, schwannoma, malignant peripheral nerve sheath tumor (MPNST) and so on. In our three cases, using reverse transcription polymerase chain reaction (RT-PCR) and direct sequencing, we detected an SS18-SSX1 fusion gene, which is specific to synovial sarcoma. In addition, we found the reduced expression of SMARCB1/INI1 in the tumor cells in two of the three cases. Through histopathological, immunohistochemical, and molecular analyses, we confirmed the diagnosis of primary gastric synovial sarcoma.
Collapse
Affiliation(s)
- Yusuke Kuboyama
- Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Yuichi Yamada
- Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Kenichi Kohashi
- Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Yu Toda
- Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Koji Kawakami
- Department of Surgery, Okinawa Kyodo Hospital, Okinawa, Japan
| | - Daichi Kitahara
- Department of Pathology, Japanese Red Cross Society Fukuoka Hospital, Fukuoka, Japan
| | - Kenichi Nishiyama
- Department of Pathology, Japanese Red Cross Society Fukuoka Hospital, Fukuoka, Japan
| | - Yuka Hiraki
- Department of Pathology, Aso Iizuka Hospital, Iizuka, Japan
| | - Masafumi Oya
- Department of Pathology, Aso Iizuka Hospital, Iizuka, Japan; Department of Pathology, Fukuoka Sanno Hospital, Fukuoka, Japan
| | - Yoshinao Oda
- Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
| |
Collapse
|
3
|
Abstract
Localized malignant mesothelioma is rare. The prognosis is generally more favorable for this condition than for diffuse malignant mesothelioma. An elderly woman recently complained of abdominal pain, fever, and weight loss. She had no history of asbestos exposure. Her serum CEA level was elevated. Plain CT revealed a mass under the left diaphragm, with liquefaction and necrosis. A contrast-enhanced scan showed circular enhancement of the mass. A subsequent biopsy of the mass revealed a poorly differentiated carcinoma. PET/CT showed a significant FDG-avid subphrenic mass without any indications of metastasis. Postoperative pathological and immunohistochemical examination confirmed a case of malignant mesothelioma.
Collapse
|
4
|
Brown M, Jersmann H, Crowhurst T, Van Vliet C, Crouch G, Badiei A. A challenging diagnosis of malignant mesothelioma with osteosarcomatous differentiation metastasizing to bone. Respirol Case Rep 2020; 8:e00664. [PMID: 32995012 PMCID: PMC7507382 DOI: 10.1002/rcr2.664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2020] [Revised: 08/24/2020] [Accepted: 09/03/2020] [Indexed: 11/29/2022] Open
Abstract
Malignant pleural mesothelioma (MPM) is an insidious primary neoplasm of the pleura that can be challenging to diagnose and is commonly considered to be only locally invasive. We present the case of a 74-year-old male who presented with clinical features of MPM but from whom pleural fluid and biopsies initially suggested benign pathology. He later developed diffuse bony metastases and re-examination of pleural biopsies using modern immunohistochemistry and molecular testing revealed a diagnosis of sarcomatoid and desmoplastic MPM with heterologous osteosarcomatous differentiation. This case not only demonstrates the rare potential of skeletal metastasis of MPM, but also highlights the importance of recognizing the utility of modern diagnostic tests and their potential to prevent the need for unnecessary invasive procedures. To our knowledge this is the first description of this rare histological sub-type presenting with skeletal metastases.
Collapse
Affiliation(s)
- Michael Brown
- Department of Thoracic MedicineRoyal Adelaide HospitalAdelaideAustralia
- Faculty of Health and Medical Sciences, Adelaide Medical SchoolUniversity of AdelaideAdelaideAustralia
| | - Hubertus Jersmann
- Department of Thoracic MedicineRoyal Adelaide HospitalAdelaideAustralia
- Faculty of Health and Medical Sciences, Adelaide Medical SchoolUniversity of AdelaideAdelaideAustralia
| | - Thomas Crowhurst
- Department of Thoracic MedicineRoyal Adelaide HospitalAdelaideAustralia
- Faculty of Health and Medical Sciences, Adelaide Medical SchoolUniversity of AdelaideAdelaideAustralia
| | - Chris Van Vliet
- Department of Anatomical PathologyPathWest Laboratory Medicine, QEII Medical CentreNedlandsWestern AustraliaAustralia
| | - Gareth Crouch
- Department of Cardiothoracic SurgeryRoyal Adelaide HospitalAdelaideAustralia
| | - Arash Badiei
- Department of Thoracic MedicineRoyal Adelaide HospitalAdelaideAustralia
- Faculty of Health and Medical Sciences, Adelaide Medical SchoolUniversity of AdelaideAdelaideAustralia
| |
Collapse
|
5
|
Marchevsky AM, Khoor A, Walts AE, Nicholson AG, Zhang YZ, Roggli V, Carney J, Roden AC, Tazelaar HD, Larsen BT, LeStang N, Chirieac LR, Klebe S, Tsao MS, De Perrot M, Pierre A, Hwang DM, Hung YP, Mino-Kenudson M, Travis W, Sauter J, Beasley MB, Galateau-Sallé F. Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel. Mod Pathol 2020; 33:281-296. [PMID: 31485011 PMCID: PMC10428660 DOI: 10.1038/s41379-019-0352-3] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2019] [Revised: 07/29/2019] [Accepted: 07/30/2019] [Indexed: 12/12/2022]
Abstract
Localized malignant mesotheliomas (LMM) is an uncommon and poorly recognized neoplasm. Its pathologic diagnosis is often surprising in patients with serosal/subserosal based localized tumors that are clinically suspicious for metastatic lesions or primary sarcomas. Once a tumor is diagnosed as "mesothelioma", LMM is often mistaken for diffuse malignant mesothelioma (DMM). Best currently available evidence about LMM was collected from the literature and cases diagnosed by members of the International Mesothelioma Panel (IMP). One hundred and one (101) LMM have been reported in the English literature. Patients had localized tumors with identical histopathologic features to DMM. Patients ranged in age from 6 to 82 years; 75% were men. Most (82%) of the tumors were intrathoracic. Others presented as intrahepatic, mesenteric, gastric, pancreatic, umbilical, splenic, and abdominal wall lesions. Tumors varied in size from 0.6 to 15 cm. Most patients underwent surgical resection and/or chemotherapy or radiation therapy. Median survival in a subset of patients was 29 months. Seventy two additional LMM from IMP institutions ranged in age from 28 to 95 years; 58.3% were men. Sixty tumors (83.3%) were intrathoracic, others presented in intraabdominal sites. Tumors varied in size from 1.2 to 19 cm. Median survival for 51 cases was 134 months. Best evidence was used to formulate guidelines for the diagnosis of LMM. It is important to distinguish LMM from DMM as their treatment and prognosis is different. A multidisciplinary approach is needed for the diagnosis of LMM as it shows identical histopathology and immunophenotype to DMM.
Collapse
MESH Headings
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Biopsy
- Child
- Diagnosis, Differential
- Evidence-Based Medicine
- Female
- Humans
- Male
- Mesothelioma, Malignant/diagnostic imaging
- Mesothelioma, Malignant/mortality
- Mesothelioma, Malignant/pathology
- Mesothelioma, Malignant/therapy
- Middle Aged
- Pleural Neoplasms/diagnostic imaging
- Pleural Neoplasms/mortality
- Pleural Neoplasms/pathology
- Pleural Neoplasms/therapy
- Predictive Value of Tests
- Prognosis
- Solitary Fibrous Tumor, Pleural/diagnostic imaging
- Solitary Fibrous Tumor, Pleural/mortality
- Solitary Fibrous Tumor, Pleural/pathology
- Solitary Fibrous Tumor, Pleural/therapy
- Tumor Burden
- Young Adult
Collapse
Affiliation(s)
| | | | - Ann E Walts
- Departments of Pathology Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | | | - Yu Zhi Zhang
- Royal Brompton and Harefield NHS Foundation Trust, London, UK
| | | | | | | | | | | | | | | | - Sonja Klebe
- Flinders University, Adelaide, SA, Australia
| | - Ming-Sound Tsao
- University Health Network, Toronto General Hospital and Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Marc De Perrot
- University Health Network, Toronto General Hospital and Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Andrew Pierre
- University Health Network, Toronto General Hospital and Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - David M Hwang
- University Health Network, Toronto General Hospital and Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Yin P Hung
- Massachusetts General Hospital, Boston, MA, USA
| | | | - William Travis
- Sloan Kettering Memorial Cancer Center, New York, NY, USA
| | | | | | | |
Collapse
|
6
|
Mann S, Khawar S, Moran C, Kalhor N. Revisiting localized malignant mesothelioma. Ann Diagn Pathol 2019; 39:74-77. [DOI: 10.1016/j.anndiagpath.2019.02.014] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2019] [Revised: 02/06/2019] [Accepted: 02/17/2019] [Indexed: 11/28/2022]
|
7
|
Guo X, Watanabe J, Takahashi K, Hayashi T, Kurose N, Sasaguri Y, Uramoto H, Iwagaki H, Nabeshima K, Yamada S. Localized malignant pleural mesothelioma arising in the interlobar fissure: a unique surgical case masquerading clinicopathologically as primary lung adenocarcinoma. SAGE Open Med Case Rep 2019; 7:2050313X18824802. [PMID: 30719319 PMCID: PMC6348540 DOI: 10.1177/2050313x18824802] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2018] [Accepted: 12/13/2018] [Indexed: 11/21/2022] Open
Abstract
An 80-year-old male with previous workplace exposure to asbestos presented with a history of an increase in the pulmonary-to-hilar mass, measuring more than 50 mm in diameter, likely in the right lower lobe. We first interpreted it as suspicious of primary lung adenocarcinoma with direct invasion to the right hilar lymph node. A right middle and lower lobectomy with partial resection of upper lobe was performed, and gross examination showed a hilar tumor lesion, involving the middle/lower lobe to hilar lymph node and looking whitish to yellow-grayish, partly adjacent to the right pulmonary artery. On microscopic examination, the tumor was located on the extrapulmonary, interlobar pleural fissure, predominantly composed of a proliferation of atypical epithelioid cells, often arranged in an irregular and fused tubular growth pattern with an involvement of pulmonary artery. Immunohistochemically, these atypical cells are positive for several mesothelial markers, including calretinin, cytokeratin 5/6, and WT-1, whereas negative for thyroid transcription factor 1. Furthermore, p16 deletions were specifically detected by fluorescence in situ hybridization, and electron microscopy showed numerous, significantly elongated microvilli. Taken together, we finally made a diagnosis of localized malignant pleural mesothelioma, epithelioid-type, arising in the right interlobar fissure between lower and middle lobes. We should be aware that, owing to its characteristic features, clinicians and pathologists might be able to raise interlobar fissure localized malignant pleural mesothelioma as one of the differential diagnoses, based on careful clinicopathological examinations.
Collapse
Affiliation(s)
- Xin Guo
- Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Uchinada, Japan
| | - Jiro Watanabe
- Laboratory of Pathology, National Hospital Organization Fukuyama Medical Center, Fukuyama, Japan
| | - Kenji Takahashi
- Department of Thoracic Surgery, National Hospital Organization Fukuyama Medical Center, Fukuyama, Japan
| | - Tatsuro Hayashi
- Department of Thoracic Surgery, National Hospital Organization Fukuyama Medical Center, Fukuyama, Japan
| | - Nozomu Kurose
- Laboratory of Pathology, National Hospital Organization Fukuyama Medical Center, Fukuyama, Japan
| | - Yasuyuki Sasaguri
- Laboratory of Pathology, National Hospital Organization Fukuyama Medical Center, Fukuyama, Japan.,Laboratory of Pathology, Fukuoka Tokushukai Hospital, Fukuoka, Japan
| | - Hidetaka Uramoto
- Department of Thoracic Surgery, Kanazawa Medical University, Uchinada, Japan
| | - Hiromi Iwagaki
- Department of Surgery, National Hospital Organization Fukuyama Medical Center, Fukuyama, Japan
| | - Kazuki Nabeshima
- Department of Pathology, Fukuoka University School of Medicine and Hospital, Fukuoka, Japan
| | - Sohsuke Yamada
- Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Uchinada, Japan.,Laboratory of Pathology, National Hospital Organization Fukuyama Medical Center, Fukuyama, Japan
| |
Collapse
|
8
|
Zardawi SJ, Li BT, Zauderer MG, Wang JW, Atmore BB, Barnes TA, Pavlakis N, Mathur MN, Clarke S. Localized malignant pleural mesothelioma with renal metastasis. Oxf Med Case Reports 2015; 2015:170-2. [PMID: 25988069 PMCID: PMC4369975 DOI: 10.1093/omcr/omu064] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2014] [Revised: 12/11/2014] [Accepted: 12/22/2014] [Indexed: 12/28/2022] Open
Abstract
Localized malignant pleural mesothelioma (LMM) is a rare subset of malignant pleural mesothelioma. Its epidemiology, biology, natural history and optimal treatment are poorly understood. We report a case of LMM treated aggressively with complete surgical resection and adjuvant radiotherapy, but subsequently complicated by local chest wall recurrence and solitary metastasis to the kidney. This case is examined in the context of a small number of cases of LMM in the literature to emphasize the existence of this rare disease entity, their unusual biological behaviour and the need for further tumour molecular and genomic research.
Collapse
Affiliation(s)
- Sarah Jane Zardawi
- Department of Medical Oncology , Royal North Shore Hospital , Sydney, NSW , Australia
| | - Bob T Li
- Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service , Memorial Sloan Kettering Cancer Center , New York, NY , USA ; Sydney Medical School , University of Sydney , Sydney, NSW , Australia
| | - Marjorie G Zauderer
- Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service , Memorial Sloan Kettering Cancer Center , New York, NY , USA ; Weill Cornell Medical College , New York, NY , USA
| | - Jennifer W Wang
- Department of Anatomical Pathology , Royal North Shore Hospital , Sydney, NSW , Australia
| | - Bryn B Atmore
- Sydney Medical School , University of Sydney , Sydney, NSW , Australia ; Department of Anatomical Pathology , Royal North Shore Hospital , Sydney, NSW , Australia
| | - Tristan A Barnes
- Department of Medical Oncology , Royal North Shore Hospital , Sydney, NSW , Australia
| | - Nick Pavlakis
- Department of Medical Oncology , Royal North Shore Hospital , Sydney, NSW , Australia ; Sydney Medical School , University of Sydney , Sydney, NSW , Australia
| | - Manu N Mathur
- Department of Cardiothoracic Surgery , Royal North Shore Hospital , Sydney, NSW , Australia
| | - Stephen Clarke
- Department of Medical Oncology , Royal North Shore Hospital , Sydney, NSW , Australia ; Sydney Medical School , University of Sydney , Sydney, NSW , Australia
| |
Collapse
|
9
|
|
10
|
Shao ZH, Gao XL, Yi XH, Wang PJ. Malignant mesothelioma presenting as a giant chest, abdominal and pelvic wall mass. Korean J Radiol 2011; 12:750-3. [PMID: 22043159 PMCID: PMC3194781 DOI: 10.3348/kjr.2011.12.6.750] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2011] [Accepted: 04/12/2011] [Indexed: 11/15/2022] Open
Abstract
Malignant mesothelioma (MM) is a relatively rare carcinoma of the mesothelial cells, and it is usually located in the pleural or peritoneal cavity. Here we report on a unique case of MM that developed in the chest, abdominal and pelvic walls in a 77-year-old female patient. CT and MRI revealed mesothelioma that manifested as a giant mass in the right flank and bilateral pelvic walls. The diagnosis was confirmed by the pathology and immunohistochemistry. Though rare, accurate investigation of the radiological features of a body wall MM may help make an exact diagnosis.
Collapse
Affiliation(s)
- Zhi-hong Shao
- Department of Radiology, Tongji Hospital of Tongji University, Shanghai 200065, China
| | | | | | | |
Collapse
|